Pioneering Phage Biocontrol
Reshaping animal biosecurity through precision biotechnology, targeted lytic predation, and sustainable antibiotic replacement.
Committed to Being a Global Leader in Industrial Bacteriophage Technologies
Founded in 2018 with a registered capital of 11.318 million RMB, Shandong New-Line Biotechnology Co., Ltd. is located in Weifang, Shandong Province?a national modern agricultural demonstration zone. Aligned with global "One Health" directives to reduce agricultural antimicrobial usage, New-Line Biotech established an innovation consortium with the Jiangsu Academy of Agricultural Sciences (JAAS). Anchored by the International Phage Research and Development Center (IPRC), we have built an elite scientific team led by over 60 Ph.D. and Master's researchers in deep collaboration with prestigious institutes including the Chinese Academy of Sciences (CAS).
Addressing critical industry pain points caused by multidrug-resistant (MDR) Escherichia coli, Salmonella, Clostridium perfringens, and Vibrio species, New-Line has developed an automated high-throughput screening platform and an expansive pathogen-phage biobank. Our commercial product portfolio covers poultry, swine, aquaculture, and ruminants, tackling antimicrobial resistance at the source and safeguarding the global food supply chain.
Research & Manufacturing Strengths
Class 10,000 Cleanrooms
Operated under strict veterinary drug GMP standards, featuring automated fermenters, tangential flow ultrafiltration (TFF), and freeze-drying suites.
Multidisciplinary Think-Tank
Collaborating with national agricultural academies to maintain real-time antimicrobial resistance surveillance and epidemiological mapping.
Full-Chain Diagnostic Support
Providing end-to-end services: pathogen isolation & serotyping → lytic susceptibility profiling → customized cocktail formulation → on-farm efficacy auditing.
Intellectual Property & Certifications
New-Line Biotech prioritizes proprietary innovation, holding numerous national utility model and invention patents covering phage isolation, high-titer concentration, formulation mixing, and cryogenic preservation.
RD01 Phage Sample Collection and Cold-Chain Transport Chamber
Utility Model Patent
RD02 Precision Filtration and Dilution Apparatus for Phage Lysates
Utility Model Patent
RD03 Specific Phage Antibody Affinity Elution Device
Utility Model Patent
RD04 Biosecure Phage Fermentation Waste Sterilization & Disposal Apparatus
Utility Model Patent
RD06 Fixed-Ratio Multi-Valence Phage Cocktail Formulation Mixer
Utility Model Patent
RD08 Tangential Flow Ultrafiltration & Phage Concentration System
Utility Model Patent
RD09 Column-Based High-Affinity Positive Phage Enrichment Device
Utility Model Patent
RD11 Industrial-Grade Phage Extraction & Microfiltration Apparatus
Utility Model Patent